Le M, Chen D, Smith K, Tran D, Fan Z
PLoS One. 2025; 20(3):e0319392.
PMID: 40073025
PMC: 11902295.
DOI: 10.1371/journal.pone.0319392.
Shin H, Yang W, Kim J, Chang H, Yoo J, Choi W
Heliyon. 2025; 11(4):e42539.
PMID: 40034272
PMC: 11874562.
DOI: 10.1016/j.heliyon.2025.e42539.
Verboven G, Huizing M, Weijer M, Ysebaert D, Ramadhan A, Wyngaert T
Cureus. 2025; 17(1):e78142.
PMID: 40018471
PMC: 11867634.
DOI: 10.7759/cureus.78142.
Budeyri I, Guckelberger O, Oppermann E, Roy D, Sliwinski S, Becker F
Cells. 2025; 14(1.
PMID: 39791707
PMC: 11720075.
DOI: 10.3390/cells14010006.
Rashid S, Puttagunta P, Pamulapati S, Yang J, Pocha S, Saba N
Int J Mol Sci. 2025; 25(24.
PMID: 39769275
PMC: 11678725.
DOI: 10.3390/ijms252413514.
Single-Cell Analysis of Bone-Marrow-Disseminated Tumour Cells.
So K, Su Z, Cheung J, Choi S
Diagnostics (Basel). 2024; 14(19).
PMID: 39410576
PMC: 11475990.
DOI: 10.3390/diagnostics14192172.
Circulating tumor cells: from new biological insights to clinical practice.
Gu X, Wei S, Lv X
Signal Transduct Target Ther. 2024; 9(1):226.
PMID: 39218931
PMC: 11366768.
DOI: 10.1038/s41392-024-01938-6.
The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer.
Wang L, Hong R, Shi S, Wang S, Chen Y, Han C
BMC Cancer. 2024; 24(1):1067.
PMID: 39210288
PMC: 11360297.
DOI: 10.1186/s12885-024-12818-1.
Novel circular RNA hsa_circ_0036683 suppresses proliferation and migration by mediating the miR-4664-3p/CDK2AP2 axis in non-small cell lung cancer.
Liu R, Zhang H, Xin J, Xie S, Jiao F, Li Y
Thorac Cancer. 2024; 15(27):1929-1945.
PMID: 39113208
PMC: 11462936.
DOI: 10.1111/1759-7714.15396.
Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y
Signal Transduct Target Ther. 2024; 9(1):132.
PMID: 38763973
PMC: 11102923.
DOI: 10.1038/s41392-024-01823-2.
Age-Related Features of the Response of Cancer Stem Cells and T Cells in Experimental Lung Cancer.
Pershina O, Ermakova N, Pakhomova A, Pan E, Sandrikina L, Zhukova M
Bull Exp Biol Med. 2024; 176(4):486-490.
PMID: 38492106
DOI: 10.1007/s10517-024-06052-9.
High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer.
Gobel A, Rachner T, Hoffmann O, Klotz D, Kasimir-Bauer S, Kimmig R
Arch Gynecol Obstet. 2024; 309(6):2789-2798.
PMID: 38413424
PMC: 11147863.
DOI: 10.1007/s00404-024-07434-0.
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.
Raskova Kafkova L, Mierzwicka J, Chakraborty P, Jakubec P, Fischer O, Skarda J
Front Immunol. 2024; 15:1342086.
PMID: 38384472
PMC: 10879685.
DOI: 10.3389/fimmu.2024.1342086.
Metastasis suppressor genes and their role in the tumor microenvironment.
Megino-Luque C, Bravo-Cordero J
Cancer Metastasis Rev. 2023; 42(4):1147-1154.
PMID: 37982987
PMC: 10842895.
DOI: 10.1007/s10555-023-10155-6.
Raman Spectroscopy Combined with Malaria Protein for Early Capture and Recognition of Broad-Spectrum Circulating Tumor Cells.
Liu X, Zhang Y, Li X, Xu J, Zhao C, Yang J
Int J Mol Sci. 2023; 24(15).
PMID: 37569448
PMC: 10419290.
DOI: 10.3390/ijms241512072.
Role of circulating tumour cells (CTCs) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).
Baa A, Sharma A, Bhaskar S, Biswas A, Thakar A, Kumar R
Ecancermedicalscience. 2023; 17:1578.
PMID: 37533950
PMC: 10393317.
DOI: 10.3332/ecancer.2023.1578.
Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients.
Cha J, Cho H, Chung J, Park J, Han K
Cancers (Basel). 2023; 15(10).
PMID: 37345161
PMC: 10216737.
DOI: 10.3390/cancers15102825.
Laser transfer for circulating tumor cell isolation in liquid biopsy.
Molpeceres C, Ramos-Medina R, Marquez A, Romero P, Gomez-Fontela M, Candorcio-Simon R
Int J Bioprint. 2023; 9(4):720.
PMID: 37323505
PMC: 10261133.
DOI: 10.18063/ijb.720.
Highly stable integration of graphene Hall sensors on a microfluidic platform for magnetic sensing in whole blood.
Shah N, Iyer V, Zhang Z, Gao Z, Park J, Yelleswarapu V
Microsyst Nanoeng. 2023; 9:71.
PMID: 37275264
PMC: 10232500.
DOI: 10.1038/s41378-023-00530-2.
NALCN is a potential biomarker and therapeutic target in human cancers.
He J, Xu J, Chang Z, Yan J, Zhang L, Qin Y
Front Genet. 2023; 14:1164707.
PMID: 37152978
PMC: 10154523.
DOI: 10.3389/fgene.2023.1164707.